B cell-targeted therapies in systemic lupus erythematosus
Leah Arbitman, Richard Furie, Himanshu Vashistha
Topics & Concepts
BelimumabHydroxychloroquineMedicineImmunologyLupus nephritisSystemic lupus erythematosusDiseaseAutoantibodyClinical trialDrugLupus erythematosusDrug developmentAutoimmune diseaseB cellB-cell activating factorPharmacologyInternal medicineAntibodyCoronavirus disease 2019 (COVID-19)Infectious disease (medical specialty)Systemic Lupus Erythematosus ResearchT-cell and B-cell ImmunologyMonoclonal and Polyclonal Antibodies Research